glutathione urine mycotoxin MycoTOX Profile® Mycotoxin Contamination: Occurrence, Biotransformation, Pathogenic

Treatments approved in the past 2 years offer potential for reversing disease progression, and emerging therapies targeting key pathways to modulate immune activation and stimulate melanocyte regeneration and differentiation are being tested in clinical trials

10.1038/onc.2012.635 97 RicoultS

This work establishes the relevance and the high mutational frequency of the common TOR1A pathogenic mutation in the European, non-Ashkenazi Jewish, population, extending the importance of screening for this mutation to all patients with generalized dystonia

Making the same recipe in bulk and posting it interstate as injection pens is really manufacturing, which needs a licence

However, we found that the DMSA had no significant effects on liver transaminases (AST and ALT), perhaps because we treated for only 3 days at a time, with 11 days in-between